2013 FDLI International Conference China-US Updates in Food and Drug Law
FDLI Conference to Offer Regulatory Insights and
Collaborative Business Strategies
Beijing, China, September 03, 2013 /PRNewswire/ — Join the Food and Drug Law Institute (FDLI) for the China-US Updates in Food and Drug Law conference, a two-day event where government officials and internationally renowned experts will discuss pharmaceutical, medical device and food law, regulation and policy in China and the United States. The conference will focus on updates in regulations, business opportunities, and challenges to producing safe products and promoting the public health.
China is an established world player in the pharmaceutical, medical device and food space. From smaller startups to multinationals, companies are staking a foothold in the region. Understanding the China Food and Drug Administration (CFDA) and other Chinese regulatory bodies is essential to understanding the Chinese market. At this meeting, you’ll hear first-hand about the creation of the CFDA—a new agency that could dramatically affect the manufacturing and importation of food, drugs and devices in China.
The global expansion of food, drug and device industries has had a tremendous impact on international trade. In China, successfully launching a food or medical product requires an understanding of access and innovation for the domestic market. At FDLI’s China-US Updates in Food and Drug Law, you’ll hear directly from experienced representatives from multinational companies about essential elements to developing a successful business model for breaking into and thriving in the Chinese market.
If you attended FDLI’s first China-US Conference in 2011, you know that this unique program provided an opportunity to learn about regulatory developments and to network for future cooperative ventures. The 2013 conference will offer even more practical discussion about the enormous amount of changes in food and drug law in both countries, including the impact of the historic Food Safety and Modernization Act (FSMA) and major changes on the horizon for the CFDA.
The Food and Drug Law Institute, founded in 1949, is a non-profit organization that provides a marketplace for discussing food and drug law issues through conferences, publications and member interaction.
For more information about the China-US Updates in Food and Drug Law conference, or FDLI, please contact Erin Jones, VP of Membership, at email@example.com or by phone at 202-222-0899.
Government officials and internationally renowned experts will discuss pharmaceutical, medical device and food law, regulation and policy in China and the United States.
Hear Q&A with FDA and Other Experts
Is the China Food and Drug Administration (CFDA) looking to FDA for any guidance?
Where does CFDA fit into the overall Chinese government?
Will CFDA be under increased scrutiny in their new role?
Download the Event Brochure
FDLI China-US Updates (English – 1MB)
FDLI China US Updates (Chinese – 1MB)